benign prostatic hypertrophy


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.

hypertrophy

 [hi-per´tro-fe]
increase in volume of a tissue or organ produced entirely by enlargement of existing cells. See also hyperplasia and proliferation. adj., adj hypertro´phic.
asymmetrical septal hypertrophy
2. the term is sometimes limited to cases of hypertrophic cardiomyopathy in which the hypertrophy is localized to the interventricular septum. See also hypertrophic obstructive cardiomyopathy.
benign prostatic hypertrophy (BPH) age-associated enlargement of the prostate resulting from proliferation of glandular and stromal elements, beginning generally in the fifth decade of life; it may cause urethral compression and obstruction. Called also benign prostatic hyperplasia and nodular hyperplasia of the prostate.
cardiac hypertrophy enlargement of myocardial cells and hyperplasia of nonmuscular cardiac components due to pressure and volume overload and sometimes to neurohumoral factors.
compensatory hypertrophy that which results from an increased workload due to some physical defect, such as in an organ where one part is defective, or in one kidney when the other is absent or nonfunctional.
functional hypertrophy hypertrophy of an organ or part caused by its increased activity.
ventricular hypertrophy hypertrophy of the myocardium of a ventricle, due to chronic pressure overload; it is manifest electrocardiographically by increased QRS complex voltage, frequently accompanied by repolarization changes.

be·nign pros·tat·ic hy·per·tro·phy

erroneous term; mistakenly used as a synonym of nodular hyperplasia of prostate.

benign prostatic hyperplasia

Benign enlargement of the prostate, which is normal after age 50 and secondary to androgen and related hormones; BPH pushes against the urethra, blocking urine flow.
 
Clinical findings
Bladder-outlet obstruction, seen in 50% of men ≥ age 60; excess enlargement may obstruct the urethra, causing urinary retention; 30+% require surgery.

benign prostatic hypertrophy

Benign prostatic hyperplasia Urology A benign enlargement of the prostate, which is normal after age 50, 2º to ♂ hormones; BPH pushes against the urethra and the bladder, blocking urine flow Clinical Bladder-outlet obstruction, seen in 50% of ♂ ≥ age 60; excess enlargement may obstruct the urethra, causing urinary retention; 30+% require surgery. See Finasteride, TURP, Urinary retention.

be·nign pros·tat·ic hy·per·tro·phy

(BPH) (bē-nīn pros-tatik hī-pĕrtrŏ-fē)
Erroneous term; mistakenly used as a synonym of nodular hyperplasia of prostate

Benign prostatic hypertrophy (BPH)

Benign prostatic hypertrophy is an enlargement of the prostate that is not cancerous. However, it may cause problems with urinating or other symptoms.
Mentioned in: Prostate Ultrasound
References in periodicals archive ?
Mullinix, PhD, chairman, president and chief executive officer of Synaptic commented, "I am pleased that PRI has asked for licenses to our alpha-1 adrenergic receptor and benign prostatic hypertrophy patent estate.
It should be stressed that residents with documentation of a spinal cord injury, benign prostatic hypertrophy, neurogenic bladder, an active urinary tract infection or Alzheimer's Disease are not good candidates for toileting schedules.
Clinical evaluation of Cernilton in benign prostatic hypertrophy. Hinyokika Kiyo.
Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer.
"We conducted a randomized clinical trial to determine if a standard daily dose of saw palmetto extract increased to a double and then a triple daily dose over 72 weeks would improve lower urinary tract symptoms attributed to benign prostatic hypertrophy," said Dr.
Blue nevus is the commonest melanocytic lesion arising in the prostate that is usually an incidental finding on transurethral resection for benign prostatic hypertrophy or at autopsy.
Keywords: Chinese medicine, Chinese herbal medicine, urology, benign prostatic hypertrophy (BPH), TURP
Low blood pressure also can be caused by medications (even those not given for the purpose of lowering blood pressure) including those taken to treat benign prostatic hypertrophy, other cardiac conditions, and Parkinson's disease.
Benign Prostatic Hypertrophy (BPH), or enlargement of the prostate, is caused by an over-production of the growth-stimulating hormone DHT, which is found in testosterone.
The most common conditions include prostatitis--inflammation of the prostate --which can cause pain and can interfere with urination and sexual functioning, and benign prostatic hypertrophy (BPH)--enlargement of the prostate--which causes frequent urination, but does not impair sexual function.
Tokyo, Japan, Jan 24, 2006 - (JCN) - Kissei Pharmaceutical announced on January 23 that it has received approval from the Ministry of Health, Labor and Welfare to manufacture URIEF Capsule 2mg/4mg, its proprietary agent for treating benign prostatic hypertrophy (BPH).
Also, reviews of herbal therapies have concluded that garlic has utility in atherosclerosis of the lower limbs and that saw palmetto is useful for benign prostatic hypertrophy.

Full browser ?